These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3643771)

  • 61. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.
    Aeschlimann JR; Dresser LD; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 1999 Feb; 43(2):335-40. PubMed ID: 9925528
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Cagni A; Chuard C; Vaudaux PE; Schrenzel J; Lew DP
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1655-60. PubMed ID: 7486895
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.
    Lowy FD; Chang DS; Lash PR
    Antimicrob Agents Chemother; 1983 Jun; 23(6):932-4. PubMed ID: 6555016
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Graninger W; Leitha T; Havel M; Georgopoulos A
    Infection; 1984; 12(4):293-5. PubMed ID: 6092279
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.
    Fung-Tomc J; Kolek B; Bonner DP
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1289-96. PubMed ID: 8328778
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1992 Apr; 36(4):856-9. PubMed ID: 1323956
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antipneumococcal activities of gemifloxacin compared to those of nine other agents.
    Davies TA; Kelly LM; Pankuch GA; Credito KL; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2000 Feb; 44(2):304-10. PubMed ID: 10639354
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria.
    Louie A; Baltch AL; Ritz WJ; Smith RP
    Chemotherapy; 1991; 37(4):275-82. PubMed ID: 1665123
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital.
    Raviglione MC; Boyle JF; Mariuz P; Pablos-Mendez A; Cortes H; Merlo A
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2050-4. PubMed ID: 2073096
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.
    Licata L; Smith CE; Goldschmidt RM; Barrett JF; Frosco M
    Antimicrob Agents Chemother; 1997 May; 41(5):950-5. PubMed ID: 9145850
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
    Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intracellular activity of vancomycin and Ly333328, a new semisynthetic glycopeptide, against methicillin-resistant Staphylococcus aureus.
    al-Nawas B; Shah PM
    Infection; 1998; 26(3):165-7. PubMed ID: 9646108
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intracellular activity of ciprofloxacin and moxifloxacin, a new 8-methoxyquinolone, against methicillin-resistant Staphylococcus aureus.
    Al-Nawas B; Shah PM
    J Antimicrob Chemother; 1998 Jun; 41(6):655-8. PubMed ID: 9687105
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
    Houlihan HH; Mercier RC; Rybak MJ
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2497-501. PubMed ID: 9371356
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus.
    Davidson RJ; Zhanel GG; Phillips R; Hoban DJ
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1261-3. PubMed ID: 1929278
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains.
    Dosler S; Gerceker AA
    Chemotherapy; 2011; 57(6):511-6. PubMed ID: 22302084
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
    Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.
    Chang VS; Dhaliwal DK; Raju L; Kowalski RP
    Cornea; 2015 Jun; 34(6):698-703. PubMed ID: 25811722
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
    Bayer AS; Morrison JO
    Antimicrob Agents Chemother; 1984 Aug; 26(2):220-3. PubMed ID: 6567464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.